- Lobbying
- boehringer AND ingelheim AND usa AND corporation
Lobbying Arrangements Results for 'Boehringer Ingelheim Usa Corporation'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Boehringer Ingelheim USA Corporation
|
BLUEBIRD STRATEGIES | |||
Details Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill. National Animal Disease Preparedness and Response Program, and the... |
Boehringer Ingelheim USA Corporation
|
HANCE SCARBOROUGH | |||
Details Issues related to 2023 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; the Animal Drug User Fee Act; and USDA programs Issues related to FY24 appropriations for anim... |
Boehringer Ingelheim USA Corporation
|
Monument Advocacy | |||
Details Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax Issues related to Intellectual Property ... |
BOEHRINGER INGELHEIM USA CORPORATION
|
BOEHRINGER INGELHEIM USA CORPORATION, formerly reported as Boehringer Ingelheim Pharmaceuticals, Inc |